|
|
Investigation of enterovirus D68 pathogenesis in the human spinal cord |
| 1K08AI171177-01 |
|
NIAID |
2022 |
|
|
Implant Biofilm Mediated Immune Response |
| 1R01AI165958-01A1 |
|
NIAID |
2022 |
|
|
Monitoring Treatment Efficacy in Leprosy |
| 1R21AI171254-01 |
|
NIAID |
2022 |
|
|
Novel Biofilm Paradigm Explaining Clinical Implant-Associated Illness. |
| 1R21AI171932-01 |
|
NIAID |
2022 |
|
|
Nanoimmunotherapy for chronic immune-mediated diseases |
| 1R41AI170413-01 |
|
NIAID |
2022 |
|
|
Developing botanical-derived chemical tools for controlling mosquito vectors |
| 1R56AI158674-01A1 |
|
NIAID |
2022 |
|
|
Mechanistic dissection of the link between virus infection and Alzheimer’s disease in a model organism |
| 3R01AI137471-05S1 |
|
NIAID |
2022 |
|
|
I-Corps: Optical design and the development of high accuracy automated tick classification using computer vision |
| 3R43AI162425-01A1S1 |
|
NIAID |
2022 |
|
|
Characterizing Shared Features of Innate Immune Cells across Neurodegenerative Diseases using Single Cell Expression and Chromatin Accessibility Data |
| 5F30AI157270-02 |
|
NIAID |
2022 |
|
|
Human antibody modification of enterovirus D68 infection |
| 5K08AI156125-02 |
|
NIAID |
2022 |
